App, the gene encoding amyloid precursor protein, is widely recognised for its association with neurodegenerative conditions, particularly Alzheimer's disease, where its cleavage product amyloid beta (Aβ) is a key pathological hallmark. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.